These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 15995579)
1. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Cockeran R; Anderson R; Feldman C Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579 [TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Lynch JP; Zhanel GG Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783 [TBL] [Abstract][Full Text] [Related]
3. Pneumococcal vaccines: an update on current strategies. Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Nuermberger EL; Bishai WR Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371 [TBL] [Abstract][Full Text] [Related]
8. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine. Garbutt J; Rosenbloom I; Wu J; Storch GA Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744 [TBL] [Abstract][Full Text] [Related]
12. A pivotal role for pneumolysin in the immunopathogenesis, treatment and prevention of pneumococcal disease. Feldman C; Anderson R S Afr Med J; 2007 Nov; 97(11 Pt 3):1141-5. PubMed ID: 18250925 [TBL] [Abstract][Full Text] [Related]
13. Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine. Benninger MS Otolaryngol Head Neck Surg; 2008 Mar; 138(3):274-8. PubMed ID: 18312870 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Toltzis P; Jacobs MR Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653 [TBL] [Abstract][Full Text] [Related]
15. Pneumolysin as a potential therapeutic target in severe pneumococcal disease. Anderson R; Feldman C J Infect; 2017 Jun; 74(6):527-544. PubMed ID: 28322888 [TBL] [Abstract][Full Text] [Related]
16. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114 [TBL] [Abstract][Full Text] [Related]
17. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015 [TBL] [Abstract][Full Text] [Related]
18. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
19. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy. Lynch JP; Zhanel GG Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429 [TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis. Marriott HM; Dockrell DH Int J Biochem Cell Biol; 2006; 38(11):1848-54. PubMed ID: 16844403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]